SCHEMBL29008449

SCHEMBL29008449

CCCc1c[nH]c(-c2c[nH]nc2Cc2ccncc2)n1

nearest known ligand 0.31

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 1/20 0.31
CDK5R1 Q15078 1/20 0.31
ITK Q08881 1/20 0.31
HRH4 Q9H3N8 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31
GABRA1 P14867 1/20 0.30
GABRB2 P47870 1/20 0.30
CYP3A4 P08684 1/20 0.30
MAPT P10636 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29008496 0.89 HPGD (0.33) CYP3A4SMN1; SMN2
SCHEMBL29008452 0.87
SCHEMBL29008499 0.86 L3MBTL1 (0.39) HRH4HRH3GABRA1GABRB2
SCHEMBL29008461 0.85
SCHEMBL29008487 0.84 PNP (0.33)
SCHEMBL29008474 0.82 HCAR2 (0.37)
SCHEMBL29008448 0.82
SCHEMBL29008472 0.81
SCHEMBL29008485 0.81 ALDH1A1 (0.33) HRH3GABRA1GABRB2
SCHEMBL29008463 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116194537-A Combination therapy with adenosine receptor antagonists 泰昂治疗公司 2023-05-30 CN disclosed